The transcription factor T-bet is a key regulator of type 1 immune responses. We examined the role of T-bet in an animal model of immune-mediated bone marrow (BM) failure, using mice carrying a germ-line
Introduction
Human aplastic anemia (AA) is characterized by pancytopenia and BM hypoplasia. [1] [2] [3] [4] In most cases, AA is an immune-mediated disease, with active destruction of hematopoietic stem and progenitor cells by T lymphocytes. 1, 5 The aberrant immune response may be triggered by drugs, viruses, or chemical exposure, but in the majority of cases the etiology is unknown. [1] [2] [3] That most patients respond to treatments with antithymocyte globulin (ATG) and other immunosuppressive agents has provided powerful evidence of the role of the immune system in the pathophysiology of AA. [6] [7] [8] [9] Excessive production of gamma interferon (IFN-γ), tumor necrosis factor-α (TNF-α), and interleukin-2 (IL-2) from patients' T cells suggests that hematopoietic cells are destroyed through a Th1 T-cell response. 10, 11 We recently observed that the Th1 transcription factor T-bet was elevated in peripheral blood T cells from patients with AA, 12 suggesting that the up-regulated T-bet signaling may contribute to the immune destruction of BM cells. T-bet is a member of the T-box family of transcription factors. Members of this family of proteins each contains a highly conserved DNA binding domain, the T-box, which binds to a specific sequence in the promoter region of different genes. T-bet is found in Th1 but not in Th2 cells and is the key regulator of Th1 development and function. 13 Mice lacking T-bet failed to develop Th1 cells and were driven toward Th2-mediated diseases. 14 We postulated that T-bet plays a critical role in the development of AA and BM failure.
We have developed murine models that mimic pathological features of human BM failure by infusing allogeneic lymph node (LN) cells into major histocompatibility complex (MHC) or
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From minor histocompatibility antigen mismatched recipients. [15] [16] [17] Donor lymphocytes infiltrate host BM and expand dramatically, accompanied by the development of severe pancytopenia and marrow hypoplasia. Increased serum IFN-γ concentration in affected animals and the effectiveness of immunosuppressive therapy with anti-IFN-γ antibody, strongly suggest that marrow destruction in this model is mediated by Th1 immune responses. 15, 16 In the current study, we tested the impact of T-bet deficiency in BM failure by using T- 
Materials and methods

Mice and cell analyses
Flow cytometry
Monoclonal antibodies to murine CD3 (clone 145-2C11), CD4 (clone GK 1.5), CD8 (clone 53-6.72), CD11b (clone M1/70), CD19 (clone ID3), CD34 (clone RAM34), CD45R (B220; clone RA3-6B2), CD95 (Fas; clone Jo2), CD117 (c-Kit; clone 2B8), erythroid cells (clone Ter119), granulocytes (Gr1/Ly6-G; clone RB6-8C5), INF-γ (clone XMG1.2) and stem cell antigen 1 (Sca1; clone E13-161) were all purchased from BD Biosciences (San Diego, CA). Each antibody was conjugated with fluorescein isothiocyanate (FITC), phycoerythrin (PE), biotin, or allophycocyanin (APC). FITC-conjugated annexin V was also from BD Biosciences. 
Statistics
All collected data were analyzed using JMP Statistical Discovery Software (SAS Institute Inc, Cary, NC) on the "fit Y by X" platform. Statistical significance was claimed at P<0.05 and P<0.01 levels respectively. Mean comparisons were carried out using the "each pair, student t" option following general variance analysis.
Results
Lymphohematopoietic cellularity in T-bet -/-mice
We first investigated the effect of T-bet deficiency on mouse lymphohematopoiesis by comparing the cellular composition in blood, BM, spleen, and LN between T-bet -/-and normal B6 mice. In peripheral blood, T-bet -/-mice showed a 23% reduction (P<0.05) in WBCs, a 31% reduction (P<0.01) in lymphocytes, a mild 9% reduction (P<0.01) in RBCs, and no change in neutrophils and platelets in comparison to normal B6 mice ( were similar between T-bet -/-and B6 mice (Table 1) . We specifically analyzed the proportions of CD4 and CD8 T cells and found no significant difference between T-bet -/-and B6 mice in peripheral blood, BM, and spleen. In LN, the CD4 cell percentage was 19% lower (P<0.05) in Tbet -/-(27 ± 1.0%) than in B6 (33 ± 1.7%) mice while the CD8 cell percentage was the same for both genotypes (29 ± 0.9% and 29 ± 1.6% respectively). Deletion of T-bet appeared to have resulted in a mild decrease in lymphocytes, especially CD4 T cells in the LN, but had no major effect on other lymphohematopoietic cell types.
Impaired LN cell function in the induction of BM failure by T-bet gene deletion
We then studied the effects of T-bet on lymphocyte function using normal B6 or T-bet -/-mice as lymphocyte donors in a mouse model of infusion-induced BM failure. Infusion of 5 × 10 6 normal B6 LN cells into sublethally-irradiated, MHC-mismatched F1 recipients produced severe pancytopenia ( Figure 1A , Table 2 ) and BM hypoplasia ( Figure 1B ) when analyzed at 12-13 days after LN cell infusion. However, infusion of the same number of LN cells from T-bet -/-donors induced no marrow failure: recipient blood and marrow cell numbers were similar to mice which had received TBI only ( Figure 1 , Table 2 ). Increasing the number of T-bet -/-LN cell infusion to 10 × 10 6 cells/recipient produced only mild marrow hypoplasia (Table 2, Figure 1 ). We infused 23 × 10 6 T-bet -/-LN cells into one 5 Gy TBI treated F1 mouse and found no sign of cytopenia in this animal at 12 days following cell infusion: neutrophils (7.2 × 10 6 /mL), red blood cells (6.7 × The osmotic pump delivery maintained plasma IFN-γ concentrations 40-60 times higher than those measured in TBI-only animals and 15-25 times higher than those in B6 LN cell-injected animals ( Figure 5B ). The high level IFN-γ was associated with lower numbers of neutrophils Figure 5C ) in comparison to mice that received T-bet -/-LN cells without IFN-γ. Mice that received TBI + IFN-γ without T-bet -/-LN cell infusion had similar evidence of hematopoietic suppression ( Figure 5C ).
We further analyzed T cells in the BM of experimental animals. Mice that received B6 LN cell infusion had drastic expansion of both CD4 and CD8 T cells (P<0.01, Figure 6A ). Figure 6C ), but the increase in CD11a + T cells was relatively small and associated with IFN-γ itself and not specifically with IFN-γ rescue of T-bet gene deleted animals ( Figure 6C ).
Recipients of T-bet
Discussion
Laboratory studies and clinical observations have suggested that the pathophysiology of AA is largely immune mediated. 1, 2 Alterations in T-cell function and cytokine production play critical roles in this disease, evidenced by the significant expansion of pathogenic T cells and upregulation in cytokines IFN-γ and TNF-α in AA patients. 18 Increased T-bet levels in circulating CD4 and CD8 T lymphocytes from AA patients further supports an abnormally up-regulated Th1
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From immune response in this disease. 12 The previously developed murine model for BM failure was analogous in these characteristic features, as infusion of MHC mismatched allogeneic LN cell induces dramatic T cell expansion and activation, with increased IFN-γ and TNF-α production, leading to massive BM cell destruction and fatal pancytopenia. 15, 16 In the current study, we provide direct evidence of the role of T-bet in our immune Observations from our current study are consistent with findings from other disease models in animals, such as atherosclerosis, type 1 diabetes, inflammatory arthritis, ulcerative colitis, and melanoma metastatic disease, in which T-bet dependent Th1 immune responses are critical. 18, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] In experimental autoimmune encephalomyelitis (EAE), the production of IFN-γ in the central nervous system was dramatically reduced in T-bet -/-mice in comparison to wild-type T-bet +/+ mice. 33 There was an increased IL10 production in T-bet -/-mice in the EAE model, suggesting compensatory up-regulation in Th2 immune response. T-bet -/-deficient mice developed spontaneous airway changes consistent with human asthma due to upregulation of Th2 response as a compensation of defective Th1 response due to T-bet deficiency. 14, 34 In our model of BM failure, deficiency of T-bet and Th1 immune response did not appear to have resulted in an obvious up-regulation of Th2 responses as Th2-related cytokines were not increased in the plasma. Instead, we observed an up-regulation in TGF-β, IL17A and IL23, all of which are cytokines related to Th17 immune responses, [34] [35] [36] [37] indicating that the lack of T-bet and Th1 immune response may have resulted in an up-regulation in Th17 immune response that might be responsible for the mild marrow failure observed in mice that received T-bet -/-LN cells.
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